Bradford Amman
2022
In 2022, Bradford Amman earned a total compensation of $492.9K as Chief Financial Officer at Vivos Therapeutics, a 55% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $20,858 |
|---|---|
| Option Awards | $195,691 |
| Salary | $256,532 |
| Other | $19,838 |
| Total | $492,919 |
Amman received $256.5K in salary, accounting for 52% of the total pay in 2022.
Amman also received $20.9K in non-equity incentive plan, $195.7K in option awards and $19.8K in other compensation.
Rankings
In 2022, Bradford Amman's compensation ranked 4,361st out of 5,753 executives tracked by ExecPay. In other words, Amman earned more than 24.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,361 out of 5,753 | 24th |
Division Manufacturing | 2,450 out of 3,133 | 22nd |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 327 out of 485 | 33rd |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 237 out of 347 | 32nd |
Industry Surgical and Medical Instruments and Apparatus | 179 out of 253 | 29th |
Source: SEC filing on October 7, 2024.
Amman's colleagues
We found two more compensation records of executives who worked with Bradford Amman at Vivos Therapeutics in 2022.